CUC Inc., a provider of health care management and operational support services headquartered in Tokyo, Japan, announced it ...

ViTAA Medical Solutions Inc. announced that the FDA has granted 510(k) clearance for the company’s AiORTA Plan. Accor ...

Johnson & Johnson MedTech announced the 1-year results from the FORWARD PAD study of its Shockwave Javelin peripheral intr ...

Surmodics, Inc. announced new real-world results from the PROWL registry evaluating the company’s Pounce thrombectomy pl ...

In this retrospective cohort study designed to assess long-term safety outcomes of drug-coated devices (DCDs) versus ...

Embolization, Inc. announced that its polymer-based coil intended for arterial and venous embolization in peripheral ...

InterVene, Inc. recently announced that it has received 510(k) clearance from the FDA for its Recana thrombectomy catheter ...

Surmodics, Inc. announced results from a sex-specific analysis of its ongoing PROWL registry evaluating real-world use of the ...

Venova Medical announced the enrollment of the first patients in the VENOS-3 pivotal study of the company’s Velocity perc ...

Gore & Associates announced trial results evaluating the investigational Viabahn Fortegra venous stent for the treatment of ...

Amplitude Vascular Systems (AVS) announced results from the first 95 patients treated in the POWER PAD II United States ...

Penumbra, Inc. announced that results of the STORM-PE randomized controlled trial (RCT) were presented at VIVA 2025, the Vascul ...